Zacks has an article today which states to hold PetMeds Express and gives the stock an $11.50 price target. From the article:
"In order for us to get more bullish on the stock, PetMed will need to drive sales growth while keeping its costs in check. As such, we think the stock is fairly valued and should trade in line with the overall market for the next six months."
This is quite a change from this analysis found at Zacks in January. To be fair, today's article seems to focus on the next six months, while the January article appears to give more of a long term analysis.